Vaccines: GB study, Pfizer prefers long interval
Extending the timing of Pfizer/BioNTech’s Covid vaccine booster to 11-12 weeks – as the UK has been experimenting with, not without controversy, since the start of its sprint vaccination campaign – greatly improves the serum’s immune efficacy compared with the 3 weeks recommended by the company.
Potrebbe interessarvi...
